Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Driehaus Capital Management LLC reported a 6.11% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Driehaus Capital Management LLC reported a 6.11% stake in Crinetics Pharmaceuticals, Inc., 6,395,922 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
6.11%
Shares
6,395,922
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
DRIEHAUS CAPITAL MANAGEMENT LLC6.11%6,395,922

Source

View original at SEC

Related